These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10473225)

  • 1. Intracellular activity of trovafloxacin against Staphylococcus aureus.
    van den Broek PJ; Koot TG; van Strijen E; Mattie H
    J Antimicrob Chemother; 1999 Aug; 44(2):193-9. PubMed ID: 10473225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of human granulocytes and monocytes on the antibacterial activity of cefetamet against Staphylococcus aureus.
    van den Broeck PJ; Seymonsbergen EM
    J Antimicrob Chemother; 1995 May; 35(5):611-22. PubMed ID: 7592174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.
    Firsov AA; Vostrov SN; Kononenko OV; Zinner SH; Portnoy YA
    Antimicrob Agents Chemother; 1999 Mar; 43(3):498-502. PubMed ID: 10049257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus.
    Meyer AP; Bril-Bazuin C; Mattie H; van den Broek PJ
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2318-22. PubMed ID: 8285612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of trovafloxacin (CP-99,219).
    Morrissey I
    J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model.
    Firsov AA; Vasilov RG; Vostrov SN; Kononenko OV; Lubenko IY; Zinner SH
    J Antimicrob Chemother; 1999 Apr; 43(4):483-90. PubMed ID: 10350376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships.
    Zinner SH; Vostrov SN; Lubenko IY; Portnoy YA; Cornaglia G; Firsov AA
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):167-71. PubMed ID: 11576789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of trovafloxacin on production of cytokines by human monocytes.
    Khan AA; Slifer TR; Remington JS
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1713-7. PubMed ID: 9661009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells.
    Pascual A; García I; Ballesta S; Perea EJ
    Antimicrob Agents Chemother; 1997 Feb; 41(2):274-7. PubMed ID: 9021179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibacterial activity of benzylpenicillin against Staphylococcus aureus ingested by granulocytes.
    van den Broek PJ; Buys LF; Aleman BM
    J Antimicrob Chemother; 1990 Jun; 25(6):931-40. PubMed ID: 2370241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes.
    Nielsen SL; Obel N; Storgaard M; Andersen PL
    J Antimicrob Chemother; 1997 May; 39(5):617-22. PubMed ID: 9184361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae.
    Kelly LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1999 May; 43(5):707-9. PubMed ID: 10382894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.
    Lubasch A; Ziege S; Brodersen B; Borner K; Koeppe P; Lode H
    Clin Microbiol Infect; 2003 Jul; 9(7):670-7. PubMed ID: 12925107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probenecid on phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes and granulocytes.
    Buisman HP; Buys LF; Langermans JA; van den Broek PJ; van Furth R
    Immunology; 1991 Oct; 74(2):338-41. PubMed ID: 1748482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria.
    Odenholt I; Cars T; Lowdin E
    J Antimicrob Chemother; 2000 Jul; 46(1):35-43. PubMed ID: 10882686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro selection of quinolone-resistant staphylococcal mutants by a single exposure to ciprofloxacin or trovafloxacin (CP-99,219) -letter-.
    Barry AL; Brown SD; Fuchs PC
    J Antimicrob Chemother; 1996 Aug; 38(2):324-7. PubMed ID: 8877554
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus.
    van der Broek PJ; Buys LF
    J Antimicrob Chemother; 1990 May; 25(5):787-95. PubMed ID: 2142684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.